Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories selling, General & Administrative Expense ($M) ($M)
Postgres DB financial_values + XBRL
Latest, Q2 2026
4,025
Period ended Jun 30, 2026
Change on a year earlier
+30.2%
3,091 in Q2 2025
History
73 quarters
Since Q2 2008
Sources
59
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Selling, General & Administrative Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 4,025 | +30.2% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,740 | +22.2% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 3,129 | +7.6% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 3,051 | +5.4% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,091 | +5.3% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,061 | +3.4% | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,907 | +6.7% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,895 | +6.3% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,936 | +7.2% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 2,959 | +7.1% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 2,724 | -8.4% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,723 | -0.3% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,740 | -0.6% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,762 | -0.9% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 2,973 | -2.5% | Form 10-K (filed 2023-02-17) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,731 | -1.3% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,757 | +1.1% | Form 10-Q (filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,787 | +0.1% | Form 10-Q (filed 2022-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 3,048 | +18.6% | Form 10-K (filed 2022-02-18) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,767 | +20.2% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 2,726 | +19.8% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 2,783 | +9.2% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 2,570 | +6.5% | Form 10-K (filed 2021-02-19) ↗ |
| Q3 2020 | Sep 30, 2020 | 2,302 | -5.7% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,276 | -6.5% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 2,548 | +2.8% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,413 | +2.3% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 2,440 | +2.7% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 2,434 | -1.3% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 2,478 | -2.5% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 2,359 | -4.8% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,377 | +12.4% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,466 | +14.7% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,542 | +4.2% | Form 10-Q (filed 2018-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,477 | +48.1% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2017 | Sep 30, 2017 | 2,115 | +29.9% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,150 | +23.8% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,440 | +43.7% | Form 10-Q (filed 2018-05-02) ↗ |
| Q4 2016 | Dec 31, 2016 | 1,673 | +1.1% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2016 | Sep 30, 2016 | 1,628 | -2.3% | Form 10-Q (filed 2016-11-03) ↗ |
| Q2 2016 | Jun 30, 2016 | 1,737 | +0.6% | Form 10-Q (filed 2016-08-03) ↗ |
| Q1 2016 | Mar 31, 2016 | 1,698 | -2.2% | Form 10-Q (filed 2016-05-04) ↗ |
| Q4 2015 | Dec 31, 2015 | 1,655 | -0.7% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | 1,666 | +4.5% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 1,727 | +4.7% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 1,737 | +7.2% | Form 10-Q (filed 2015-05-06) ↗ |
| Q4 2014 | Dec 31, 2014 | 1,666 | +8.1% | Form 10-Q (filed 2015-11-05) ↗ |
| Q3 2014 | Sep 30, 2014 | 1,595 | -1.1% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2014 | Jun 30, 2014 | 1,649 | -3.8% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2014 | Mar 31, 2014 | 1,620 | -9.3% | Form 10-Q (filed 2015-05-06) ↗ |
| Q4 2013 | Dec 31, 2013 | 1,541 | +33.1% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2013 | Sep 30, 2013 | 1,612 | -16.0% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2013 | Jun 30, 2013 | 1,714 | -5.5% | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2013 | Mar 31, 2013 | 1,786 | -3.0% | Form 10-Q (filed 2014-05-07) ↗ |
| Q4 2012 | Dec 31, 2012 | 1,158 | -60.2% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 1,920 | -54.7% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2012 | Jun 30, 2012 | 1,814 | -34.3% | Form 10-Q (filed 2013-08-06) ↗ |
| Q1 2012 | Mar 31, 2012 | 1,842 | -35.4% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 2,906 | +3.9% | Form 10-K (filed 2012-02-21) ↗ |
| Q3 2011 | Sep 30, 2011 | 4,239 | +58.6% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 2,762 | +0.7% | Form 10-Q (filed 2011-08-04) ↗ |
| Q1 2011 | Mar 31, 2011 | 2,850 | +31.8% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | 2,797 | +25.7% | Form 10-K (filed 2011-02-18) ↗ |
| Q3 2010 | Sep 30, 2010 | 2,673 | +28.1% | Form 10-Q (filed 2010-11-05) ↗ |
| Q2 2010 | Jun 30, 2010 | 2,743 | +35.5% | Form 10-Q (filed 2010-08-05) ↗ |
| Q1 2010 | Mar 31, 2010 | 2,162 | +4.4% | Form 10-Q (filed 2010-05-04) ↗ |
| Q4 2009 | Dec 31, 2009 | 2,225 | -3.1% | Form 10-K (filed 2010-02-19) ↗ |
| Q3 2009 | Sep 30, 2009 | 2,086 | +0.9% | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 2,024 | -1.4% | Form 10-Q (filed 2009-08-07) ↗ |
| Q1 2009 | Mar 31, 2009 | 2,071 | – | Form 10-Q (filed 2010-05-04) ↗ |
| Q4 2008 | Dec 31, 2008 | 2,297 | – | Form 10-K (filed 2010-02-19) ↗ |
| Q3 2008 | Sep 30, 2008 | 2,068 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2008 | Jun 30, 2008 | 2,052 | – | Form 10-Q (filed 2009-08-07) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Selling, General & Administrative Expense ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-sga
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.